GSK plc’s CVRx CVRX Stock Holding History

GSK plc’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.18M	Hold	1,007,583	–	–	0.86%	12
2026 Q1	$9.53M	Hold	1,007,583	–	–	1.59%	10
2025 Q4	$7.15M	Buy	+1,007,583	New	+$9.2M	0.9%	11

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GSK plc's CVRX Position: Q2 2026 in Review

GSK plc held its CVRx (CVRX) position steady in Q2 2026 at 1,007,583 shares worth $5.18M. The position accounts for 0.86% of the portfolio, ranked #12.

GSK plc first reported a position in CVRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.53M in Q1 2026. 88 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

GSK plc held 1,007,583 shares of CVRx worth $5.18M as of Q2 2026.
GSK plc left its CVRx share count unchanged in Q2 2026.
CVRx made up 0.86% of GSK plc's portfolio in Q2 2026, its #12 holding.
GSK plc first reported a position in CVRx in Q4 2025 and has held it in 3 quarters since.
GSK plc's CVRx position peaked at $9.53M in Q1 2026.
88 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on GSK plc's 13F filing for Q2 2026, filed 13 Aug 2026.